Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $57.69 ($2.3M) on 2019-02-19, disclosed to the SEC on 2019-02-21.
Seasonal sale ($2.3M) by Chief Executive Officer — this insider has traded FGEN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.67 | 918 | $53K | 2.3% |
| 2 | $57.69 | 18,100 | $1.0M | 45.9% |
| 3 | $58.26 | 800 | $47K | 2.0% |
| 4 | $56.71 | 9,050 | $513K | 22.6% |
| 5 | $56.76 | 500 | $28K | 1.2% |
| 6 | $57.41 | 418 |
| $24K |
| 1.1% |
| 7 | $57.47 | 9,850 | $566K | 24.9% |
| Total | $57.41 avg | 39,636 | $2.3M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |